Stopped: Due to the impossibility of predicting pulmonary shunts during segmental or sectoral treatment, the sponsor declared the early termination of enrolment in the trial.
The goal of this monocentric interventional study is to evaluate the efficacy, in terms of objective response rate, of the 188Re-SSS lipiodol SIRT in patients with non-operable HCC.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
The objective response rate
Timeframe: through study completion, an average of 4 year